Llano, Daniel A <br/><br/>
VGF in Cerebrospinal Fluid Combined With Conventional Biomarkers Enhances Prediction of Conversion From MCI to AD.  [electronic resource] 

 -  Alzheimer disease and associated disorders   
 - 307-314 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1546-4156 
<br/><br/><label>Standard No.: </label>10.1097/WAD.0000000000000328  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Alzheimer Disease--diagnosis<br/>Amyloid beta-Peptides--cerebrospinal fluid<br/>Biomarkers--cerebrospinal fluid<br/>Brain<br/>Cognitive Dysfunction--diagnosis<br/>Disease Progression<br/>Female<br/>Hippocampus<br/>Humans<br/>Male<br/>Peptide Fragments--cerebrospinal fluid<br/>tau Proteins--cerebrospinal fluid